|
|
Volumn 13, Issue 4, 2009, Pages 348-349
|
|
Neuro-imaging: Structural and functional imaging
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALZHEIMER DISEASE VACCINE;
N2 [2 (3,5 DIFLUOROPHENYL) 2 HYDROXYACETYL] N1 (6,7 DIHYDRO 5 METHYL 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL)ALANINAMIDE;
AGING;
ALZHEIMER DISEASE;
ARTICLE;
BRAIN ATROPHY;
COGNITIVE DEFECT;
DISEASE COURSE;
DISEASE MARKER;
GENOTYPE;
HIPPOCAMPUS;
HUMAN;
MUTANT;
NERVE CELL DIFFERENTIATION;
NERVE DEGENERATION;
NEUROIMAGING;
NEUROPATHOLOGY;
NONHUMAN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PRIORITY JOURNAL;
WILD TYPE;
ALZHEIMER DISEASE;
ANIMALS;
BIOLOGICAL MARKERS;
BRAIN;
CLINICAL TRIALS AS TOPIC;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
DRUG DISCOVERY;
HUMANS;
MAGNETIC RESONANCE IMAGING;
RESEARCH DESIGN;
|
|
EID: 65249143255
PISSN: 12797707
EISSN: None
Source Type: Journal
DOI: 10.1007/s12603-009-0039-4 Document Type: Article |
|
Times cited : (4)
|
|
References (5)
|
